• Issue

    Alimentary Pharmacology & Therapeutics: Volume 16, Issue 2

    167-331
    February 2002
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Review Articles

Current concepts in the management of Helicobacter pylori infection—The Maastricht 2-2000 Consensus Report

P. Malfertheiner,  F. Mégraud,  C. O'Morain,  A. P. S. Hungin,  R. Jones,  A. Axon,  D. Y. Graham,  G. Tytgat,  The European Helicobacter Pylori Study Group (EHPSG) , 
  • Pages: 167-180
  • First Published: 18 January 2002

Immunosuppressants in distal ulcerative colitis

G. Falasco,  R. Zinicola,  A. Forbes, 
  • Pages: 181-187
  • First Published: 18 January 2002

Single subject trials as a research instrument in gastrointestinal pharmacology

L. G. Madsen,  P. Bytzer, 
  • Pages: 189-196
  • First Published: 18 January 2002

Original Articles

Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study

L. Langmead,  C. Dawson,  C. Hawkins,  N. Banna,  S. Loo,  D. S. Rampton, 
  • Pages: 197-205
  • First Published: 18 January 2002

Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis

N. Mahmud,  D. O'Toole,  N. O'Hare,  P. J. Freyne,  D. G. Weir,  D. Kelleher, 
  • Pages: 207-215
  • First Published: 18 January 2002

Effects of meal consistency and ingested fluid volume on the intragastric distribution of a drug model in humans—a magnetic resonance imaging study

H. Faas,  A. Steingoetter,  C. Feinle,  T. Rades,  H. Lengsfeld,  P. Boesiger,  M. Fried,  W. Schwizer, 
  • Pages: 217-224
  • First Published: 18 January 2002

Effects of 5-HT3 antagonism on postprandial gastric volume and symptoms in humans

B. Kuo,  M. Camilleri,  D. Burton,  B. Viramontes,  S. McKinzie,  G. Thomforde,  M. K. O'Connor,  B. H. Brinkmann, 
  • Pages: 225-233
  • First Published: 18 January 2002

Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver disease

G. Marino,  V. K. Rustgi,  G. Salzberg,  L. B. Johnson,  P. C. Kuo,  J. S. Plotkin,  D. A. Flockhart, 
  • Pages: 235-242
  • First Published: 18 January 2002

Interferon-α plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers

J. A. Moreno-Monteagudo,  A. Castro,  A. De Pedro,  J. A. Lorenzo,  M. Fernández-Bermejo,  S. Lopez,  L. García-Buey,  M. J. Borque,  J. D. Pedreira,  R. Moreno-Otero, 
  • Pages: 243-249
  • First Published: 18 January 2002

Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy

A. S. L. Cheng,  H. L. Y. Chan,  N. W. Y. Leung,  C. T. Liew,  K. F. To,  P. B. S. Lai,  J. J. Y. Sung, 
  • Pages: 251-260
  • First Published: 18 January 2002

The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease

J. J. Ofman,  G. H. Dorn,  M. B. Fennerty,  R. Fass, 
  • Pages: 261-273
  • First Published: 18 January 2002

Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer

J. S. Kim,  S. G. Kim,  I. J. Choi,  M. J. Park,  B. G. Kim,  H. C. Jung,  I. S. Song, 
  • Pages: 275-280
  • First Published: 18 January 2002

Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus

C. E. M. De Block,  I. H. De Leeuw,  J. J. P. M. Bogers,  P. A. Pelckmans,  M. M. Ieven,  E. A. E. Van Marck,  V. Van Hoof,  E. Máday,  K. L. Van Acker,  L. F. Van Gaal, 
  • Pages: 281-289
  • First Published: 18 January 2002

Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies

S. K. Poon,  C. S. Chang,  J. Su,  C. H. Lai,  C. C. Yang,  G. H. Chen,  W. C. Wang, 
  • Pages: 291-296
  • First Published: 18 January 2002

Nizatidine and cisapride enhance salivary secretion in humans

K. Adachi,  M. Ono,  A. Kawamura,  M. Yuki,  H. Fujishiro,  Y. Kinoshita, 
  • Pages: 297-301
  • First Published: 18 January 2002

Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors

B. I. Hirschowitz,  J. Simmons,  J. Mohnen, 
  • Pages: 303-313
  • First Published: 18 January 2002

High rate of post-therapeutic resistance after failure of macrolide–nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study

U. Peitz,  M. Sulliga,  K. Wolle,  A. Leodolter,  U. Von Arnim,  S. Kahl,  M. Stolte,  G. Börsch,  J. Labenz,  P. Malfertheiner, 
  • Pages: 315-324
  • First Published: 18 January 2002

Sulphide-induced energy deficiency in colonic cells is prevented by glucose but not by butyrate

S. J. Hulin,  S. Singh,  M. A. S. Chapman,  A. Allan,  M. J. S. Langman,  M. C. Eggo, 
  • Pages: 325-331
  • First Published: 18 January 2002